We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Using Cells as Models

Mark Wigglesworth PhD, Director of High Throughput Screening at AstraZeneca tells us how using cells as models is improving the success of drug discovery.